Glucagon
Glucagon is an intervention with 64 clinical trials. Currently 8 active trials ongoing. Historical success rate of 93.0%.
Success Metrics
Based on 40 completed trials
Phase Distribution
Phase Distribution
24
Early Stage
13
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
40 of 48 finished
16.7%
8 ended early
8
trials recruiting
64
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes
To Determine Tolerability to Glucagon Infusion in Obese Subjects
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Clinical Trials (64)
Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes
To Determine Tolerability to Glucagon Infusion in Obese Subjects
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET
Pancreatic Clamp in NAFLD
Investigating the Acute Effects of Increasing Glucagon Exposure in Healthy Participants
Studies of Insulin and Glucagon Action in the Liver
Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents
The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance.
Liver Glycogen and Hypoglycemia in Humans
Glucagon Use in Colonoscopies
Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1
The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA
The Underlying Mechanisms Regarding the Effect of Glucagon on the Kidneys Will be Investigated in Healthy Males.
Dexamethasone/Pancreatic Clamp P&F
The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover
Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes
Glucagon Resistance in Patients With NAFLD
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 64